En super effektiv kur mod kræft - Antineoplastons - blev udviklet af Dr. Stanislaw R. Burzynski allerede i 1970-erne. Lige siden har FDA og medicinalindustrien gjort ALT for at forhindre ham i at redde menneskeliv med sin metode. Dokumentarfilm skaberen Eric Merola har nu lavet 2 dokumentarfilm om det. Fra hans website:
My first documentary, Burzynski: Cancer Is Serious Business remains an international success seen by tens of millions of people worldwide. This project was presented on Netflix, PBS, The Documentary Channel, and various international television outlets. A recent YouTube post has garnered more than 2 million views in less than 2 weeks. The positive reception of the Burzynski story led me to produce its sequel, Burzynski: Cancer Is Serious Business, Part II
Beskrivelsen til den første film:
3,121,338 views - 1 Jan 2023 #FreeDocumentary #FilmIsNow
Burzynski: The Cancer Cure Cover-up is the story of a pioneering biochemist who discovered a unique and proprietary method of successfully treating most cancers.
Director: Eric Merola
🔴 Want to be notified when we post new videos? SUBSCRIBE to the channel and click the bell icon -
http://bit.ly/SubFIN This documentary takes the audience on a near 50-year journey both Dr. Burzynski and his patients have been enduring in order to obtain FDA-approved clinical trials of Antineoplastons. Defying the face of skepticism, legal attacks from state and federal agencies, and a powerful propaganda campaign to stop Burzynski – this doctor and his patients are still going strong.
Beskrivelsen til den anden film:
160,691 views - 7 Jan 2023 #FreeDocumentary #FilmIsNow
In the compelling follow up to the internationally award winning documentary Burzynski: The Cancer Cure Cover-up, Burzynski: Cancer is Serious Business Part 2 explores the continued journey of an innovative cancer therapy called Antineoplastons and its clinical testing sanctioned by the United States FDA. This documentary also features a real-time stories of the turbulent journeys of cancer patients being treated at the Burzynski Clinic in Houston, Texas—in the face of an onslaught of harassment and intimidation from a concerted “Astroturf” campaign by the cancer industry.
When Antineoplastons are approved, it will mark the first time in history that one single scientist, and not a pharmaceutical company, will hold the exclusive patent and distribution rights on a medical breakthrough of this magnitude.
Director: Eric Merola
